Furthermore, nPKC-θi2 also induced the expression of effector cytokines in PBMCs isolated from immunotherapy-resistant melanoma patients, suggesting that PKC-θ induces the dysfunctional CD8+ T-cell phenotype in immunotherapy-resistant tumors. Here, PRRT2 is linked to melanoma.